|
|
|
|
To contact the Biomédica Department of Sistemas Genómicos please go to Biomédica
|
|
|
|
|
If you wish to contact the Web Manager please go to the Webmaster
|
|
|
|
-
Contact us directly and an expert in pharmacogenetics will assist you. We study carefully the best approach for each case.
-
Sample taking. The type of sample required depends on the kind of marker to be analyzed:
|
|
| Biomarker |
|
Sample required |
|
|
| TPMT |
|
5 ml of peripheral blood in a EDTA tube |
|
|
| Rearrangement BCR/ABL1 |
|
3 ml of bone marrow in heparine, or
5 ml of peripheral blood in a PaxGene tube |
|
|
| UGT1A1 |
|
5 ml of peripheral blood in a EDTA tube |
|
|
| HER2/neu |
|
Parafined tissue sample with tumour tissue and slide with a cross-section of the block stained with haematoxylin |
|
|
| Chromosome 5q |
|
3 ml of aspirated bone marrow in heparine |
|
|
| PML/RAR |
|
3 ml of aspirated bone marrow in heparine, or
5 ml of peripheral blood in a PaxGene tube |
|
|
| NAT 2 |
|
5 ml of peripheral blood in a EDTA tube |
|
|
-
Please send the sample to our center along with the request form for the analysis. The form is available in our web site.
-
Analysis phase: study based on the genetic analysis and the identification of the different genetic variants linked to drug activity and metabolism.
-
Post-analysis phase: processing of identified genetic variants (alleles) and comparison with existing data.
-
Result report: submission of a report with a drug response and clinical interpretation that includes found biomarkers and their influence in the clinical course of the disease and patient response to treatment protocol.
|
|
